Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Remedent, Inc (REMI) Licenses GlamSmile for New Dental Veneer Technology

The smiles are bigger around the offices of Remedent and Den-Mat Holdings this week. The two companies signed an international distribution and collaboration agreement Monday for new cosmetic dentistry products. Den-Mat has acquired exclusive rights to domestically and internationally manufacture, market and distribute GlamSmile technology to enhance its own porcelain Lumineers line.

GlamSmile encompasses Remedent’s (OTCBB: REMI) single-motion veneer placement tray technology, proprietary veneer fabrication technique, and computer imaging design and digital preview technology. In turn, this will enable Den-Mat to proceed with a November launch to dentistry professionals of LumiTray, a one-tray process for easy, efficient placement of Lumineers.

“This important agreement offers Den-Mat access to Remedent’s next generation technology that will further enhance the creation, precision and placement of our high quality Lumineers and new cutting edge products for an improved cosmetic dentistry experience for both professionals and consumers,” said Den-Mat Holdings CEO Nicholas L. Teti, Jr.

A news release states that GlamSmile “is a revolutionary cosmetic dental system that substantially expands the consumer and professional dental market for veneers.” The veneers are delivered to a dentist already prepared for a simple, single-motion veneer placement, resulting in lower pricing.

Remedent develops, manufactures and markets oral care and cosmetic dentistry products with distribution in more than 35 countries. Based in Deurle, Belgium and El Segundo, CA, Remedent serves both the professional dental community and the consumer over-the-counter market.

“Den-Mat’s integration of this proprietary technology will further enhance its aesthetic offerings and improve customer ease of use and satisfaction,” said Ed Johnson, DLJ Merchant Banking Partners managing director. “We are very excited about the great potential from this transaction for both Den-Mat and Remedent.”

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *